AR102762A1 - Secuencia de oligonucleótidos para uso en ingeniería de rutas metabólicas - Google Patents
Secuencia de oligonucleótidos para uso en ingeniería de rutas metabólicasInfo
- Publication number
- AR102762A1 AR102762A1 ARP150103828A ARP150103828A AR102762A1 AR 102762 A1 AR102762 A1 AR 102762A1 AR P150103828 A ARP150103828 A AR P150103828A AR P150103828 A ARP150103828 A AR P150103828A AR 102762 A1 AR102762 A1 AR 102762A1
- Authority
- AR
- Argentina
- Prior art keywords
- sequence
- fragment
- recombinant dna
- rna
- oligonucleotide sequence
- Prior art date
Links
- 108091034117 Oligonucleotide Proteins 0.000 title abstract 5
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 title abstract 2
- 230000002503 metabolic effect Effects 0.000 title 1
- 239000012634 fragment Substances 0.000 abstract 7
- 108091032973 (ribonucleotides)n+m Proteins 0.000 abstract 3
- 108020004511 Recombinant DNA Proteins 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 238000013518 transcription Methods 0.000 abstract 2
- 230000035897 transcription Effects 0.000 abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 101710172711 Structural protein Proteins 0.000 abstract 1
- 108020004566 Transfer RNA Proteins 0.000 abstract 1
- 239000005515 coenzyme Substances 0.000 abstract 1
- 239000013613 expression plasmid Substances 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 108020004999 messenger RNA Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y503/00—Intramolecular oxidoreductases (5.3)
- C12Y503/01—Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
- C12Y503/01005—Xylose isomerase (5.3.1.5)
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Abstract
La presente solicitud comprende una secuencia de oligonucleótidos artificiales que puede iniciar la trascripción de un gen en diversas condiciones a un nivel alto. Además, la solicitud se refiere a un fragmento de ADN recombinante que comprende la secuencia de oligonucleótidos artificiales, un plásmido de expresión que comprende el fragmento de ADN recombinante y una célula huésped transformada con el fragmento de ADN recombinante. Reivindicación 1: Secuencia de oligonucleótidos, caracterizada por que aumenta la tasa de trascripción de un ARN tipificado como fragmento de ARN mensajero que codifica para una proteína seleccionada del grupo que consiste en enzimas, proteínas estructurales, coenzimas, transportadores, anticuerpos, hormonas y reguladores, como fragmento de ARN regulador, como fragmento enzimáticamente activo de ARN o como fragmento de ARN de transferencia, donde la secuencia de oligonucleótido tiene al menos un 80% de identidad de secuencia con la SEQ ID Nº 1.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14195026.1A EP3026116B1 (en) | 2014-11-26 | 2014-11-26 | Oligonucleotide sequence for use in pathway engineering |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR102762A1 true AR102762A1 (es) | 2017-03-22 |
Family
ID=52000679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP150103828A AR102762A1 (es) | 2014-11-26 | 2015-11-24 | Secuencia de oligonucleótidos para uso en ingeniería de rutas metabólicas |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US10400244B2 (es) |
| EP (1) | EP3026116B1 (es) |
| CN (1) | CN108064291B (es) |
| AR (1) | AR102762A1 (es) |
| AU (1) | AU2015352801B2 (es) |
| BR (1) | BR112017011182B1 (es) |
| CA (1) | CA2967751C (es) |
| DK (1) | DK3026116T3 (es) |
| EA (1) | EA037161B1 (es) |
| ES (1) | ES2626804T3 (es) |
| HR (1) | HRP20170884T1 (es) |
| HU (1) | HUE032941T2 (es) |
| MY (1) | MY176630A (es) |
| PL (1) | PL3026116T3 (es) |
| RS (1) | RS56018B1 (es) |
| SI (1) | SI3026116T1 (es) |
| WO (1) | WO2016083180A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112004930A (zh) * | 2018-03-27 | 2020-11-27 | 巴斯夫欧洲公司 | 木糖代谢酵母 |
| DK3690052T5 (da) * | 2019-01-29 | 2024-08-26 | Clariant Produkte Deutschland Gmbh | Kimær promotor til anvendelse i metabolsk manipulation |
| US20210062178A1 (en) * | 2019-06-21 | 2021-03-04 | The Regents Of The University Of California | Novel xylose isomerase gene and polypeptide and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7504493B2 (en) * | 1997-01-23 | 2009-03-17 | The John Hopkins University | Characterization of the yeast transcriptome |
| SE0202090D0 (sv) * | 2002-05-08 | 2002-07-04 | Forskarpatent I Syd Ab | A modifierd yeast consuming L-arabinose |
| AU2009320163B2 (en) * | 2008-10-27 | 2014-10-02 | Butamax(Tm) Advanced Biofuels Llc | Carbon pathway optimized production hosts for the production of isobutanol |
| JP2010136627A (ja) * | 2008-12-09 | 2010-06-24 | Nippon Oil Corp | 酵母にガラクトースを利用させる方法 |
| HUE026191T2 (en) * | 2009-06-26 | 2016-05-30 | Archer Daniels Midland Co | Enhancement of Alcohol Extraction using a modified yeast strain containing recombinant nucleic acid encoding apirase |
| CN102060930B (zh) * | 2010-11-30 | 2013-05-29 | 上海交通大学 | hHscFv-Rcr功能蛋白及转基因烟草的制备方法 |
| DE102012007491A1 (de) * | 2012-04-11 | 2013-10-17 | Evonik Industries Ag | Neue Enzyme |
| CN104797708A (zh) * | 2012-08-29 | 2015-07-22 | 拉勒曼德匈牙利流动性管理有限责任公司 | 酵母中用于木质纤维素衍生的寡聚物cbp的酶的表达 |
| EP2922952A2 (en) * | 2012-11-23 | 2015-09-30 | DSM IP Assets B.V. | Itaconic acid and itaconate methylester production |
| US8669076B1 (en) | 2013-03-11 | 2014-03-11 | E I Du Pont De Nemours And Company | Cow rumen xylose isomerases active in yeast cells |
-
2014
- 2014-11-26 SI SI201430240T patent/SI3026116T1/sl unknown
- 2014-11-26 DK DK14195026.1T patent/DK3026116T3/en active
- 2014-11-26 PL PL14195026T patent/PL3026116T3/pl unknown
- 2014-11-26 ES ES14195026.1T patent/ES2626804T3/es active Active
- 2014-11-26 RS RS20170511A patent/RS56018B1/sr unknown
- 2014-11-26 HU HUE14195026A patent/HUE032941T2/en unknown
- 2014-11-26 EP EP14195026.1A patent/EP3026116B1/en active Active
-
2015
- 2015-11-16 WO PCT/EP2015/076715 patent/WO2016083180A1/en not_active Ceased
- 2015-11-16 BR BR112017011182-9A patent/BR112017011182B1/pt not_active IP Right Cessation
- 2015-11-16 US US15/529,577 patent/US10400244B2/en active Active
- 2015-11-16 EA EA201791156A patent/EA037161B1/ru unknown
- 2015-11-16 CA CA2967751A patent/CA2967751C/en active Active
- 2015-11-16 CN CN201580064337.1A patent/CN108064291B/zh active Active
- 2015-11-16 MY MYPI2017000774A patent/MY176630A/en unknown
- 2015-11-16 AU AU2015352801A patent/AU2015352801B2/en not_active Ceased
- 2015-11-24 AR ARP150103828A patent/AR102762A1/es not_active Application Discontinuation
-
2017
- 2017-06-09 HR HRP20170884TT patent/HRP20170884T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20170884T1 (hr) | 2017-09-08 |
| US20170314029A1 (en) | 2017-11-02 |
| ES2626804T3 (es) | 2017-07-26 |
| EP3026116B1 (en) | 2017-03-15 |
| EA201791156A1 (ru) | 2017-09-29 |
| DK3026116T3 (en) | 2017-06-06 |
| US10400244B2 (en) | 2019-09-03 |
| PL3026116T3 (pl) | 2017-09-29 |
| CN108064291A (zh) | 2018-05-22 |
| RS56018B1 (sr) | 2017-09-29 |
| WO2016083180A1 (en) | 2016-06-02 |
| AU2015352801B2 (en) | 2018-11-01 |
| EP3026116A1 (en) | 2016-06-01 |
| CA2967751C (en) | 2020-08-11 |
| AU2015352801A1 (en) | 2017-05-25 |
| CN108064291B (zh) | 2022-01-11 |
| BR112017011182A2 (pt) | 2018-02-06 |
| SI3026116T1 (sl) | 2017-10-30 |
| BR112017011182A8 (pt) | 2022-08-30 |
| BR112017011182B1 (pt) | 2024-02-15 |
| HUE032941T2 (en) | 2017-11-28 |
| CA2967751A1 (en) | 2016-06-02 |
| MY176630A (en) | 2020-08-19 |
| EA037161B1 (ru) | 2021-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2019003842A1 (es) | Vectores virales recombinantes con tropismo modificado y usos de estos para la introducción dirigida de material genético a células humanas. | |
| ZA202003137B (en) | Nucleic acid, composition and conjugate containing same, and preparation method and use | |
| MX2018013919A (es) | Portadores hibridos para cargas de acido nucleico. | |
| BR112017008022A2 (pt) | célula, polinucleotídeo, veículo, e, métodos para modificação de um genoma de células cho e para preparação de uma proteína de interesse. | |
| AR090417A1 (es) | Plantas resistentes al glifosato y metodos asociados | |
| AR117738A2 (es) | Neurotoxinas recombinantes de clostridium botulinum | |
| AR092712A1 (es) | Una proteina con actividad cetosa 3-epimerasa | |
| FI3599251T3 (fi) | Cd20-antigeeniin kohdentuvan kimeerisen antigeenireseptorin rakentaminen ja sillä muunnettujen t-solujen aktiivisuuden tunnistaminen | |
| MX356792B (es) | Elementos de regulacion de plantas y sus usos. | |
| MX2015017110A (es) | Integracion dirigida. | |
| EP4219725A3 (en) | Altering gene expression in modified t cells and uses thereof | |
| MX2020005458A (es) | Variantes de alfa-amilasa y polinucleotidos que codifican las mismas. | |
| WO2014202616A3 (en) | Rasamsonia gene and use thereof | |
| BR112016025519A2 (pt) | engenharia genética in vivo com vetores de adenovírus | |
| NZ609903A (en) | Expression vector for high level expression of recombinant proteins | |
| MX2016005488A (es) | Vector hsv oncolitico. | |
| ES2721309T3 (es) | Composición para preparar tagatosa y método para preparar tagatosa a partir de fructosa | |
| WO2013186563A3 (en) | Factor viii sequences | |
| JP2019523767A5 (es) | ||
| MX2018010288A (es) | Sistema de transposon y metodos de uso. | |
| MX2021001578A (es) | Proteina asociada a crispr novedosa y uso de la misma. | |
| MX2020005724A (es) | Variantes de alfa-amilasa y polinucleotidos que codifican las mismas. | |
| AR095662A1 (es) | Elementos reguladores de plantas y sus usos | |
| PE20211238A1 (es) | Tratamiento antisentido del sindrome de angelman | |
| AR102410A1 (es) | Polipéptidos que tienen actividad xilanasa con una tasa de conversión alta de polisacáridos que contienen xilosa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |